Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katsuhiko Iseki is active.

Publication


Featured researches published by Katsuhiko Iseki.


Redox Report | 2003

Structure–activity relationship of 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone)

Kazutoshi Watanabe; Yasuhiro Morinaka; Katsuhiko Iseki; Toshiaki Watanabe; Satoshi Yuki; Hiroyoshi Nishi

Abstract This paper describes the discovery of a novel free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone, 1), as a potent antioxidant agent against lipid peroxidation. The structure-activity relationship of edaravone indicated that lipophilic substituents were essential to show its lipid peroxidation-inhibitory activity. In vivo studies revealed that edaravone showed brain-protective activity in a transient ischemia model.


Tetrahedron Letters | 1986

A convenient synthesis of β-alkynylpropionic acids from β-propiolactones. Synthesis of 4,4,5,5-tetradehydro-9(O)-methano-Δ6(9α)-PGI1

Masaki Shinoda; Katsuhiko Iseki; Tomei Oguri; Yosio Hayasi; Shun-ichi Yamada; Masakatsu Shibasaki

A new prostacyclin analog, 4,4,5,5-tetradehydro-9(0)-methano-gD6(9α)-PGI, has been synthesized by utilizing the regiocontrolled cleavage of the β-propiolactone uith the dialkylaluminum acetylide.


Archive | 1986

Prophylactic and therapeutic agent for circulatory disorders

Hiroyoshi Nishi; Toshiaki Watanabe; Satoshi Yuki; Yasuhiro Morinaka; Katsuhiko Iseki; Hiroko Sakurai


Archive | 1987

Prophylactic and therapeutic composition for circulatory disorders and method of treatment

Hiroyoshi Nishi; Toshiaki Watanabe; Satoshi Yuki; Yasuhiro Morinaka; Katsuhiko Iseki; Hiroko Sakurai


Archive | 1985

Pharmaceuticals containing prostaglandin I2

Akira Ishibashi; Daijiro Horii; Toshiji Kanayama; Katsuhiko Iseki; Masaki Shinoda; Chiyoko Ishiyama; Yosio Hayashi; Masakatsu Shibasaki; Mikiko Sodeoka; Yuji Ogawa; Toshiaki Mase


Archive | 1986

(2-chloro-3-oxo-1-alkenyl)bicyclo(3.3.0)octane derivative

Masakatsu Shibasaki; Katsuhiko Iseki; Masaki Shinoda; Chiyoko Aoki; Yoshio Hayashi


Archive | 1986

(2-Chloro-3-oxo-1-alkenyl)bicyclo (3.3.0.) octene derivative and process for preparing the same

Masakatsu Shibasaki; Katsuhiko Iseki; Masaki Shinoda; Chiyoko Aoki; Yoshio Hayashi


Archive | 1985

4-phenylphthalazine derivatives, their preparation and their use as pharmaceuticals

Yasuhiro Morinaka; Katsuhiko Iseki; Toshiji Kanayama; Toshiaki Watanabe; Hiroyoshi Nishi


Archive | 1986

Prostacyclins and pharmaceuticals containing the same

Mikiko Sodeoka; Masakatsu Shibasaki; Katsuhiko Iseki; Chiyoko Aoki; Masaki Shinoda; Yoshio Hayashi; Toshiji Kanayama


Archive | 1986

Agent prophylactique et thérapeutique pour maladies de circulation du sang

Hiroyoshi Nishi; Toshiaki Watanabe; Satoshi Yuki; Yasuhiro Morinaka; Katsuhiko Iseki; Hiroko Sakurai

Collaboration


Dive into the Katsuhiko Iseki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Satoshi Yuki

Mitsubishi Tanabe Pharma

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge